Download Medical Notes on Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations Medical Notes

About This Presentation

Description:This report titled, “Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations” is by the IQVIA Institute and is an analysis of the orphan drug market. The report explores this topic of orphan drugs’ orphan and non-orphan indication approvals and their associated patent and market exclusivities. The report also examines orphan drug pricing relative to patient numbers, how those prices change over time, and – in a first-of-its-kind comprehensive analysis – compares current disease epidemiology to the number of treated patients to demonstrate the challenges in bringing orphan drugs to patients even after they are approved.

Tags:Healthcare, Orphan Drugs, United States, market, pricing, disease epidemiology

Published on: Jul 20, 2020 | Views : 1417 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Social Media and the Indian Healthcare Industry

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

Social Media and the Indian Healthcare Industry

Get the insurance companies out of my healthcare

Emerging Biopharma’s Contribution to Innovation

Importance of food we eat and physical activity etc on our wellness

The Impact of COVID-19 on Cancer Treatment in Japan

India Pharma 2020 - Propelling access and acceptance realizing true potential

Diabetes Costs and Affordability in the United States

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

Biopharma Companies Join Forces to Fight COVID-19

How did the Indian Pharmaceutical Market Become Self-Sufficient

HEALTH A TO Z